Fundraising FoxOrbiMed — 2017 Investments
7 investments dated 2017 · listed companies and verified rows first · show all
Aadi Bioscience develops therapies targeting mTOR-driven diseases using precision medicine and albumin-bound nanoparticle technology, applying genomic profiling to identify patients most likely to benefit from mTOR inhibition.
BiotechHealthtechMorristown, US
Scott Giacobello(Executive Officer)inBryan Ball(Executive Officer)Dave Lennon(Executive Officer, Director)inDavid Dornan(Executive Officer)James Murphy(Executive Officer)Stephen Pakola(Executive Officer)
Board seatChau Khuong· per SEC Form D · $41.8M raise · filed Mar 2017
Co-investors3B Future Health FundAlly Bridge GroupDecheng CapitalVivo Capital
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPaul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in
Board seatChau Khuong· per SEC Form D · $42M raise · filed May 2017
Co-investorsAtlas VentureCLI VenturesNew Enterprise Associates (NEA)NSG VenturesPfizer Venture InvestmentsSofinnova Ventures+1 more
Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.
BiotechHardwareMedical DevicesLebanon, US
Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)
Co-investorsSV Health InvestorsBorealis VenturesMithril Capital ManagementNeomed ManagementPolaris PartnersSands Capital Ventures+1 more
Azura is an onchain trading platform that lets users trade any onchain asset using USD without bridging, gas, or wallet management, at zero fees.
Crypto & Web3Fintech
Co-investorsAlliance DAO (ex DeFi Alliance)De Fi Alliance HoldingsInitialized CapitalThanefield CapitalTranspose Platform ManagementRaj Gokal+2 more
LogicBio is a biotechnology company focused on research and development of treatments for rare diseases, investigating new targets, modalities, and technologies for patients and their families worldwide.
BiotechHealthtechCambridge, US
Leszek Lisowski(Executive Officer, Director)Mark A. Kay(Director)Adi Barzel(Executive Officer, Director)
BoardErez Chimovits(Director)in
Co-investorsAndera PartnersPontifax Venture CapitalSBI JI Innovation Advisory Ltd.Arix Bioscience
HealthtechSan Francisco, US
Matthew F. Krummel, Ph.D.(Director)Steven P. James(Executive Officer, Director, Promoter)inLeon Chen, Ph.D.(Director)Carol Gallagher(Director)inJoshua Resnick, M.D.(Director)
BoardMichael Powell(Director)
Co-investorsMission Bay CapitalMission BiocapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sofinnova VenturesSofinnova Venture Partners
PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations.
BiotechHealthtechLongevityCranbury, US
David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Co-Founder & Member, Scientific Advisory Board)David H. Mack(Co-Founder, President & CEO)Thomas Shenk(Co-Founder)Deepika Jalota(Chief Development Officer)
Co-investorsAvoro Capital AdvisorsNextech InvestOUP (Osage University Partners)RA CapitalViking GlobalWellington Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.